Bloomberg Law
March 16, 2022, 10:25 AM

Pfizer Asks FDA to Clear Another Booster For Older Adults (2)

Riley Griffin
Riley Griffin
Bloomberg News

Pfizer Inc. said it has asked U.S. regulators for clearance of an additional Covid-19 booster shot for seniors, in a bid to protect vulnerable adults as immunity provided by the first three doses wanes.

The New York-based drugmaker and its German partner BioNTech SE said on Tuesday that they have sought an emergency-use authorization from the Food and Drug Administration for a second booster of their vaccine, Comirnaty, for people 65 and older who have already received a booster of any of the authorized Covid-19 vaccines.

Pfizer and BioNTech said they submitted data to the FDA from Israel, which began ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.